Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Immunopathology and Immunotherapy of Non-Hodgkin Lymphoma Publisher



Ebadi M1 ; Sadeghi MA2, 3 ; Reddy NM4 ; Rezaei N5, 6, 7
Authors

Source: Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors Published:2020


Abstract

Immunotherapy has been increasingly applied to the treatment of various malignancies in recent decades. Considering the limited clinical effectiveness obtained by other treatment modalities in the treatment of non-Hodgkin lymphoma (NHL), attention has been drawn to immunotherapy as an efficient alternative or complementary therapy. Importantly, the unique immunopathology of NHL makes it quite amenable to immunotherapeutic treatment. This chapter aims to discuss a broad spectrum of these approaches, ranging from monoclonal antibodies (mAbs) which were developed in the early days of immunotherapy to novel techniques developed in just the recent years. Furthermore, various applications of these agents of immunotherapy, both as monotherapy and as combinational therapy, are explored. Since a clear concept of the pathobiology of NHL is necessary for efficient immunotherapy, a brief description with an emphasis on suitable targets for immunotherapy is given before discussing various immunotherapies. © Springer Nature Switzerland AG 2020. All rights reserved.
1. Immunopathology and Immunotherapy of Non-Hodgkin Lymphoma, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)
2. Immunopathology and Immunotherapy of Hodgkin Lymphoma, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
3. Immunopathology and Immunotherapy of Hodgkin Lymphoma, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)
Experts (# of related papers)
Other Related Docs
5. Anti-Cd20 Antibody Treatment for B-Cell Malignancies, Resistance to Anti-CD20 Antibodies and approaches for their Reversal: Volume 2 (2023)
8. Monoclonal Antibodies for Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
15. Immunotherapy of Cancers Comes of Age, Expert Review of Clinical Immunology (2017)
16. Car-Modified T-Cell Therapy for Cancer: An Updated Review, Artificial Cells# Nanomedicine and Biotechnology (2016)
17. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
18. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
19. Cancer Immunotherapy Confers a Global Benefit, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
20. Neurological Adverse Effects of Chimeric Antigen Receptor T-Cell Therapy, Expert Review of Clinical Immunology (2023)